Silvariño, R., Peluffo, L., Cabrera, E., San Román, S., Baccino, C. and Noboa, O. 2022. Autosomal dominant polycystic kidney disease. Who can benefit from tolvaptan therapy?. Revista Médica del Uruguay. 38, 3 (Nov. 2022), e38312. DOI:https://doi.org/10.29193/RMU.38.3.11.